W. L. Gore & Associates Receives Innovative Technology Designation from Vizient, Inc. for GORE® SYNECOR Biomaterial

Designation recognizes products that bring improvements to the
healthcare industry

FLAGSTAFF, Ariz.–(BUSINESS WIRE)–W. L. Gore & Associates announced GORE® SYNECOR
Biomaterial for hernia repair has received the Innovative Technology
designation from Vizient, Inc., the largest member-driven healthcare
performance improvement company in the country. The designation was
based on reviews of GORE SYNECOR Biomaterial by hospital experts who
attended the Vizient Innovative Technology Exchange in September 2016.
The event provided medical technology suppliers the opportunity to
demonstrate their product and gain direct feedback from 1300 onsite
clinical experts and healthcare providers on the impact their products
may have on improving clinical care, safety, or benefits to an
organization’s care and business model.

For years surgeons in hernia repair faced a choice between a permanent
synthetic mesh, offering strength but potentially higher complication
risks, or a bioabsorbable mesh (biosynthetic or biologic) with lower
complication risks, but also leading to possibly higher recurrence rates
and the need for multi-stage procedures.

Constructed with GORE® BIO-A® web
scaffold combined with a permanent knit of dense monofilament PTFE fiber
that may reduce the risk of harboring bacteria, GORE SYNECOR Biomaterial
provides both high strength and rapid vascularity, for durable, lasting
repairs. The non-porous, bioabsorbable film minimizes tissue attachment
at the visceral side, making it an ideal product for intraperitoneal
positioning, laparoscopic and robotic use.

“GORE SYNECOR Biomaterial was engineered to be a unique solution in
delivering a single-stage hernia repair,” explains David Lane, Business
Unit Leader for General Medical Products, W. L. Gore & Associates, Inc.
“Our goal is to work with hospitals and surgeons in meeting their
unsolved needs while delivering clear value and promoting optimal
outcomes for patients.”

“Due to the number of products and services being released and marketed
as ‘innovative’, member hospitals truly value the peer-review system in
place at Vizient to help them identify products worth further evaluation
at their own facilities,” said Debbie Archer, director of procurement
and leader of Vizient’s Innovative Technology program for suppliers.
“After a review of the GORE SYNECOR Biomaterial, Vizient’s members
agreed this product offers unique and incremental benefit over other
products available on the market today, and recommended it for an
Innovative Technology designation.”

Vizient, Inc. represents the combined strengths of the organizations
formerly known as VHA Inc., University HealthSystem Consortium, Novation
and MedAssets’ Spend and Clinical Resource Management. Since 2003,
nearly 2200 new and innovative products and technologies have been
submitted through the Vizient
Innovative Technology program
. Vizient works with member-led
councils and task forces to identify and review potentially innovative
products. If it is determined that a product is innovative, a contract
may be awarded outside of Vizient’s competitive bid cycle.


At Gore Medical, we have provided creative therapeutic solutions to
complex medical problems for 40 years. During that time, 40 million
innovative Gore Medical Devices have been implanted, saving and
improving the quality of lives worldwide. Our extensive family of
products includes vascular grafts, endovascular and interventional
devices, surgical meshes for hernia and soft tissue reconstruction,
staple line reinforcement materials, and sutures for use in vascular,
cardiac, and general surgery. We are one of a select few companies to
appear on all of the U.S. “100 Best Companies to Work For” lists since
the rankings debuted in 1984. For more information, visit www.goremedical.com.

Products listed may not be available in all markets. GORE®,
BIO-A®, and SYNECOR are trademarks of W. L. Gore & Associates.
AV1477-EN1 DECEMBER 2016


Chempetitive Group for W. L. Gore & Associates
Andrea Vuturo,